SZOSTAK M ANNE

Director SZOSTAK M ANNE sold 2,187 shares (89.4% of holdings) at $647.33, leaving only 259 shares; stock now -6.0% from 52-week high.

Director SZOSTAK M ANNE executed a substantial reduction in her IDXX stake, selling 2,187 shares at $647.33 and retaining just 259 shares post-transaction, representing a -89.4% net change in her open position. The sale occurred near the stock's 52-week high—the transaction price of $647.33 is within 0.8% of the 52-week peak of $682.78, and the stock currently trades at $641.72, -6.0% from that high. Her prior three sales at IDXX yielded positive 90-day returns (+2.0%, +2.3%, +5.2%), indicating those previous exits were poorly timed (stock subsequently rose); this pattern suggests prior sales did not precede material declines. The timing context here—selling near a 52-week high after the stock gained +13.5% over 30 days and +24.8% over 90 days—differs from her recent pattern of selling before subsequent appreciation, though the forward outcome remains unknown.

Director Anne M. Szostak sold 2,306 shares at $512.97 avg for $1.2M, cutting holdings by 56.1%.

M Anne Szostak, a Director at IDEXX Laboratories, executed two separate sales on 2025-05-21, totaling 2,306 shares for $1,182,916.79 at a blended average price of $512.97. This represents a substantial reduction in her holdings from 4,107 shares to 1,801 shares, a 56.1% decrease. The current stock price of $501.57 sits below both transaction prices, suggesting the sales occurred near a local peak relative to today's valuation. Prior to this filing, Szostak's cross-ticker track record showed only one prior sell; at IDXX specifically, her single prior sale on 2025-02-07 experienced a 90-day return of +5.2%, indicating the stock rose after that sell—poorly timed in exit-timing terms. The company trades at a P/E of 45.06 on annual revenue growth of 6.5%, suggesting a premium valuation that may have motivated this substantial reduction in an already concentrated director position.

Director SZOSTAK sold 3,000 IDXX shares (49.5% of holdings) at $465.94; stock down 19.4% from 52-week high.

SZOSTAK M ANNE, a Director, executed a substantial sale of 3,000 shares representing 49.5% of her pre-transaction holdings on 2025-02-07 at $465.94 per share, reducing her ownership to 3,061 shares. The transaction occurs with the stock trading 19.4% below its 52-week high of $576.87 and having recovered 11.2% over the prior 30 days and 9.1% over 90 days, suggesting the sell was not at peak valuations but follows recent strength. The company maintains solid fundamentals with latest quarterly revenue of $975,543,000 and net income of $232,841,000, supporting a market cap of $38,068,999,140.24 and P/E of 43.94. The near-halving of her direct shareholding is material enough to warrant investor attention, though without prior trade history or scheduling flags in the filing, the motivation remains opaque.